168 related articles for article (PubMed ID: 36372294)
1. Associations between the kynurenine pathway and the brain in patients with major depressive disorder-A systematic review of neuroimaging studies.
Wang L; Feng Z; Zheng T; Dai G; Wang M; Zhou L; Zheng Y; Chen G
Prog Neuropsychopharmacol Biol Psychiatry; 2023 Mar; 121():110675. PubMed ID: 36372294
[TBL] [Abstract][Full Text] [Related]
2. Relationship between neurotoxic kynurenine metabolites and reductions in right medial prefrontal cortical thickness in major depressive disorder.
Meier TB; Drevets WC; Wurfel BE; Ford BN; Morris HM; Victor TA; Bodurka J; Teague TK; Dantzer R; Savitz J
Brain Behav Immun; 2016 Mar; 53():39-48. PubMed ID: 26546831
[TBL] [Abstract][Full Text] [Related]
3. Cross-sectional relationship between kynurenine pathway metabolites and cognitive function in major depressive disorder.
Zhou Y; Zheng W; Liu W; Wang C; Zhan Y; Li H; Chen L; Ning Y
Psychoneuroendocrinology; 2019 Mar; 101():72-79. PubMed ID: 30419374
[TBL] [Abstract][Full Text] [Related]
4. Fronto-limbic neuroimaging biomarkers for diagnosis and prediction of treatment responses in major depressive disorder.
Lai CH
Prog Neuropsychopharmacol Biol Psychiatry; 2021 Apr; 107():110234. PubMed ID: 33370569
[TBL] [Abstract][Full Text] [Related]
5. Ultra-high field imaging in Major Depressive Disorder: a review of structural and functional studies.
Cattarinussi G; Delvecchio G; Maggioni E; Bressi C; Brambilla P
J Affect Disord; 2021 Jul; 290():65-73. PubMed ID: 33993082
[TBL] [Abstract][Full Text] [Related]
6. Selective association of cytokine levels and kynurenine/tryptophan ratio with alterations in white matter microstructure in bipolar but not in unipolar depression.
Comai S; Melloni E; Lorenzi C; Bollettini I; Vai B; Zanardi R; Colombo C; Valtorta F; Benedetti F; Poletti S
Eur Neuropsychopharmacol; 2022 Feb; 55():96-109. PubMed ID: 34847455
[TBL] [Abstract][Full Text] [Related]
7. Grey and white matter structure associates with the activation of the tryptophan to kynurenine pathway in bipolar disorder.
Poletti S; Melloni E; Aggio V; Colombo C; Valtorta F; Benedetti F; Comai S
J Affect Disord; 2019 Dec; 259():404-412. PubMed ID: 31610997
[TBL] [Abstract][Full Text] [Related]
8. The possible role of the kynurenine pathway in adolescent depression with melancholic features.
Gabbay V; Klein RG; Katz Y; Mendoza S; Guttman LE; Alonso CM; Babb JS; Hirsch GS; Liebes L
J Child Psychol Psychiatry; 2010 Aug; 51(8):935-43. PubMed ID: 20406333
[TBL] [Abstract][Full Text] [Related]
9. Multimodal imaging reveals a complex pattern of dysfunction in corticolimbic pathways in major depressive disorder.
Nugent AC; Farmer C; Evans JW; Snider SL; Banerjee D; Zarate CA
Hum Brain Mapp; 2019 Sep; 40(13):3940-3950. PubMed ID: 31179620
[TBL] [Abstract][Full Text] [Related]
10. A combination of neuroimaging and plasma metabolomic analysis suggests inflammation is associated with white matter structural connectivity in major depressive disorder.
Wei J; Zhang Z; Du Y; Yang X; Zhao L; Ni P; Ni R; Gong M; Ma X
J Affect Disord; 2022 Dec; 318():7-15. PubMed ID: 36057287
[TBL] [Abstract][Full Text] [Related]
11. Does tryptophan degradation along the kynurenine pathway mediate the association between pro-inflammatory immune activity and depressive symptoms?
Quak J; Doornbos B; Roest AM; Duivis HE; Vogelzangs N; Nolen WA; Penninx BW; Kema IP; de Jonge P
Psychoneuroendocrinology; 2014 Jul; 45():202-10. PubMed ID: 24845191
[TBL] [Abstract][Full Text] [Related]
12. The kynurenine pathway in adolescent depression: preliminary findings from a proton MR spectroscopy study.
Gabbay V; Liebes L; Katz Y; Liu S; Mendoza S; Babb JS; Klein RG; Gonen O
Prog Neuropsychopharmacol Biol Psychiatry; 2010 Feb; 34(1):37-44. PubMed ID: 19778568
[TBL] [Abstract][Full Text] [Related]
13. Molecular, Functional, and Structural Imaging of Major Depressive Disorder.
Zhang K; Zhu Y; Zhu Y; Wu S; Liu H; Zhang W; Xu C; Zhang H; Hayashi T; Tian M
Neurosci Bull; 2016 Jun; 32(3):273-85. PubMed ID: 27142698
[TBL] [Abstract][Full Text] [Related]
14. Neuroimaging of major depression in Parkinson's disease: Cortical thickness, cortical and subcortical volume, and spectroscopy findings.
Chagas MHN; Tumas V; Pena-Pereira MA; Machado-de-Sousa JP; Carlos Dos Santos A; Sanches RF; Hallak JEC; Crippa JAS
J Psychiatr Res; 2017 Jul; 90():40-45. PubMed ID: 28222355
[TBL] [Abstract][Full Text] [Related]
15. How do substance use disorders compare to other psychiatric conditions on structural brain abnormalities? A cross-disorder meta-analytic comparison using the ENIGMA consortium findings.
Navarri X; Afzali MH; Lavoie J; Sinha R; Stein DJ; Momenan R; Veltman DJ; Korucuoglu O; Sjoerds Z; van Holst RJ; Hester R; Orr C; Cousijn J; Yucel M; Lorenzetti V; Wiers R; Jahanshad N; Glahn DC; Thompson PM; Mackey S; Conrod PJ
Hum Brain Mapp; 2022 Jan; 43(1):399-413. PubMed ID: 32643841
[TBL] [Abstract][Full Text] [Related]
16. Beta-defensin 1, aryl hydrocarbon receptor and plasma kynurenine in major depressive disorder: metabolomics-informed genomics.
Liu D; Ray B; Neavin DR; Zhang J; Athreya AP; Biernacka JM; Bobo WV; Hall-Flavin DK; Skime MK; Zhu H; Jenkins GD; Batzler A; Kalari KR; Boakye-Agyeman F; Matson WR; Bhasin SS; Mushiroda T; Nakamura Y; Kubo M; Iyer RK; Wang L; Frye MA; Kaddurah-Daouk R; Weinshilboum RM
Transl Psychiatry; 2018 Jan; 8(1):10. PubMed ID: 29317604
[TBL] [Abstract][Full Text] [Related]
17. Diagnosis of Major Depressive Disorder Using Machine Learning Based on Multisequence MRI Neuroimaging Features.
Li Q; Dong F; Gai Q; Che K; Ma H; Zhao F; Chu T; Mao N; Wang P
J Magn Reson Imaging; 2023 Nov; 58(5):1420-1430. PubMed ID: 36797655
[TBL] [Abstract][Full Text] [Related]
18. Investigation of the Relationship among Cortisol, Pro-inflammatory Cytokines, and the Degradation of Tryptophan into Kynurenine in Patients with Major Depression and Suicidal Behavior.
Messaoud A; Rym M; Wahiba D; Neffati F; Najjar MF; Gobbi G; Manchia M; Valtorta F; Lotfi G; Comai S
Curr Top Med Chem; 2022; 22(25):2119-2125. PubMed ID: 34503408
[TBL] [Abstract][Full Text] [Related]
19. Dysbiosis of the Gut Microbiota and Kynurenine (Kyn) Pathway Activity as Potential Biomarkers in Patients with Major Depressive Disorder.
Lin P; Li D; Shi Y; Li Q; Guo X; Dong K; Chen Q; Lou X; Li Z; Li P; Jin W; Chen S; Sun Y; Sun J; Cheng X
Nutrients; 2023 Apr; 15(7):. PubMed ID: 37049591
[TBL] [Abstract][Full Text] [Related]
20. Systematic transdiagnostic review of magnetic-resonance imaging results: Depression, anxiety disorders and their co-occurrence.
Sindermann L; Redlich R; Opel N; Böhnlein J; Dannlowski U; Leehr EJ
J Psychiatr Res; 2021 Oct; 142():226-239. PubMed ID: 34388482
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
